Gene · 4751
Papers2,227
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,227
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CEP55 as a promising biomarker and therapeutic target on gallbladder cancer. | Front Oncol | 2023 | 37274251 | PubTator, text mining | PubMed |
| Applications of organoid technology to brain tumors. | CNS Neurosci Ther | 2023 | 37248629 | PubTator, text mining | PubMed |
| Epigenetic and Tumor Microenvironment for Prognosis of Patients with Gastric Cancer. | Biomolecules | 2023 | 37238607 | PubTator, text mining | PubMed |
| NEK2 promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathway. | Discov Oncol | 2023 | 37233832 | PubTator, text mining | PubMed |
| Autoinhibitory mechanism controls binding of centrosomin motif 1 to γ-tubulin ring complex. | J Cell Biol | 2023 | 37213089 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis on exportins in lung adenocarcinoma and lung squamous cell carcinoma. | J Thorac Dis | 2023 | 37197486 | PubTator, text mining | PubMed |
| An Integrative Multi-Omics Analysis of The Molecular Links between Aging and Aggressiveness in Thyroid Cancers. | Aging Dis | 2023 | 37191407 | PubTator, text mining | PubMed |
| Role of β-Catenin Activation in the Tumor Immune Microenvironment and Immunotherapy of Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 37190239 | PubTator, text mining | PubMed |
| The Enhanced Expression of ZWILCH Predicts Poor Survival of Adrenocortical Carcinoma Patients. | Biomedicines | 2023 | 37189849 | PubTator, text mining | PubMed |
| Genes whose expressions in the primary lung squamous cell carcinoma are able to accurately predict the progression of metastasis through lymphatic system, inferred from a bioinformatics analyses. | Sci Rep | 2023 | 37185598 | PubTator, text mining | PubMed |
| Epigenetic Alterations from Barrett's Esophagus to Esophageal Adenocarcinoma. | Int J Mol Sci | 2023 | 37175524 | PubTator, text mining | PubMed |
| EML4-ALK biology and drug resistance in non-small cell lung cancer: a new phase of discoveries. | Mol Oncol | 2023 | 37149843 | PubTator, text mining | PubMed |
| Sustained Shugoshin 1 downregulation reduces tumor growth and metastasis in a mouse xenograft tumor model of triple-negative breast cancer. | Cell Div | 2023 | 37122033 | PubTator, text mining | PubMed |
| A Study on the Planarian Model Confirms the Antioxidant Properties of Tameron against X-ray- and Menadione-Induced Oxidative Stress. | Antioxidants (Basel) | 2023 | 37107327 | PubTator, text mining | PubMed |
| Integration of Chemoinformatics and Multi-Omics Analysis Defines ECT2 as a Potential Target for Cancer Drug Therapy. | Biology (Basel) | 2023 | 37106813 | PubTator, text mining | PubMed |
| STIL/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer. | J Transl Med | 2023 | 37101292 | PubTator, text mining | PubMed |
| Never in mitosis gene A-related kinase-8 promotes proliferation, migration, invasion, and stemness of breast cancer cells via β-catenin signalling activation. | Sci Rep | 2023 | 37100815 | PubTator, text mining | PubMed |
| Conserved NIMA kinases regulate multiple steps of endocytic trafficking. | PLoS Genet | 2023 | 37099601 | PubTator, text mining | PubMed |
| Identification of a novel spirocyclic Nek2 inhibitor using high throughput virtual screening. | Bioorg Med Chem Lett | 2023 | 37094724 | PubTator, text mining | PubMed |
| Exploring the hub genes and mechanisms of Daphne altaica treating esophageal squamous cell carcinoma based on network pharmacology and bioinformatics analysis. | J Cancer Res Clin Oncol | 2023 | 37087696 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4751/papers?page=13